Hyderabad Telangana, India

Dharmapuri Gajula


Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2018-2020

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Dharmapuri Gajula: Innovator in Pharmaceutical Synthesis

Introduction

Dharmapuri Gajula is a notable inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of pharmaceutical synthesis, particularly in the development of processes for the preparation of important compounds. With a total of 2 patents to his name, Gajula's work is recognized for its innovative approaches and practical applications.

Latest Patents

Gajula's latest patents include a process for the preparation of enzalutamide. This invention relates to an improved method that utilizes conventional synthesis techniques, avoiding the use of microwave irradiation and harmful reagents. Additionally, he has developed a process for the preparation of 4-isothiocyanato-2-(trifluoromethyl) benzonitrile, which serves as an intermediate in the synthesis of enzalutamide. These advancements highlight his commitment to enhancing pharmaceutical manufacturing processes.

Career Highlights

Gajula is currently associated with Laurus Labs Private Limited, a company known for its focus on pharmaceutical development and manufacturing. His role at Laurus Labs has allowed him to contribute to various innovative projects that aim to improve drug synthesis and production efficiency.

Collaborations

Throughout his career, Gajula has collaborated with talented professionals, including Kameswar Rao Chivukula and Veera Venkateswara Rao Karuturi. These collaborations have fostered a creative environment that encourages the exchange of ideas and expertise in the field of pharmaceutical research.

Conclusion

Dharmapuri Gajula's contributions to pharmaceutical synthesis through his innovative patents and collaborative efforts underscore his importance in the industry. His work continues to influence the development of safer and more efficient drug manufacturing processes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…